Ombitasvir plus paritaprevir plus ritonavir with or without ribavirin in treatment-naive and treatment-experienced patients with genotype 4 chronic hepatitis C virus infection (PEARL-I): a randomised, open-label trial
2015 ◽
Vol 149
(4)
◽
pp. 971-980.e1
◽
2017 ◽
Vol 66
(1)
◽
pp. S728-S729
◽
2019 ◽
Vol 4
(2)
◽
pp. 127-134
◽